These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
239 related items for PubMed ID: 19995837
1. Cognitive impairment predicts conversion to multiple sclerosis in clinically isolated syndromes. Zipoli V, Goretti B, Hakiki B, Siracusa G, Sorbi S, Portaccio E, Amato MP. Mult Scler; 2010 Jan; 16(1):62-7. PubMed ID: 19995837 [Abstract] [Full Text] [Related]
2. Cognitive impairment and its relation with disease measures in mildly disabled patients with relapsing-remitting multiple sclerosis: baseline results from the Cognitive Impairment in Multiple Sclerosis (COGIMUS) study. Patti F, Amato MP, Trojano M, Bastianello S, Tola MR, Goretti B, Caniatti L, Di Monte E, Ferrazza P, Brescia Morra V, Lo Fermo S, Picconi O, Luccichenti G, COGIMUS Study Group. Mult Scler; 2009 Jul; 15(7):779-88. PubMed ID: 19542262 [Abstract] [Full Text] [Related]
3. Neuropsychological and MRI measures predict short-term evolution in benign multiple sclerosis. Portaccio E, Stromillo ML, Goretti B, Zipoli V, Siracusa G, Battaglini M, Giorgio A, Bartolozzi ML, Guidi L, Sorbi S, Federico A, Amato MP, De Stefano N. Neurology; 2009 Aug 18; 73(7):498-503. PubMed ID: 19641173 [Abstract] [Full Text] [Related]
4. Magnetic resonance imaging predictors of conversion to multiple sclerosis in the BENEFIT study. Moraal B, Pohl C, Uitdehaag BM, Polman CH, Edan G, Freedman MS, Hartung HP, Kappos L, Miller DH, Montalban X, Lanius V, Sandbrink R, Barkhof F. Arch Neurol; 2009 Nov 18; 66(11):1345-52. PubMed ID: 19901165 [Abstract] [Full Text] [Related]
5. Effects of immunomodulatory treatment with subcutaneous interferon beta-1a on cognitive decline in mildly disabled patients with relapsing-remitting multiple sclerosis. Patti F, Amato MP, Bastianello S, Caniatti L, Di Monte E, Ferrazza P, Goretti B, Gallo P, Morra VB, Lo Fermo S, Picconi O, Tola MR, Trojano M, COGIMUS Study Group. Mult Scler; 2010 Jan 18; 16(1):68-77. PubMed ID: 19995846 [Abstract] [Full Text] [Related]
6. Conventional and magnetization transfer MRI predictors of clinical multiple sclerosis evolution: a medium-term follow-up study. Rovaris M, Agosta F, Sormani MP, Inglese M, Martinelli V, Comi G, Filippi M. Brain; 2003 Oct 18; 126(Pt 10):2323-32. PubMed ID: 12937086 [Abstract] [Full Text] [Related]
7. APOE-epsilon4 is not associated with cognitive impairment in relapsing-remitting multiple sclerosis. Portaccio E, Goretti B, Zipoli V, Nacmias B, Stromillo ML, Bartolozzi ML, Siracusa G, Guidi L, Federico A, Sorbi S, De Stefano N, Amato MP. Mult Scler; 2009 Dec 18; 15(12):1489-94. PubMed ID: 19965518 [Abstract] [Full Text] [Related]
8. Cognitive assessment and quantitative magnetic resonance metrics can help to identify benign multiple sclerosis. Amato MP, Portaccio E, Stromillo ML, Goretti B, Zipoli V, Siracusa G, Battaglini M, Giorgio A, Bartolozzi ML, Guidi L, Sorbi S, Federico A, De Stefano N. Neurology; 2008 Aug 26; 71(9):632-8. PubMed ID: 18725589 [Abstract] [Full Text] [Related]
9. Baseline MRI predicts future attacks and disability in clinically isolated syndromes. Tintoré M, Rovira A, Río J, Nos C, Grivé E, Téllez N, Pelayo R, Comabella M, Sastre-Garriga J, Montalban X. Neurology; 2006 Sep 26; 67(6):968-72. PubMed ID: 17000962 [Abstract] [Full Text] [Related]
10. Infratentorial lesions predict long-term disability in patients with initial findings suggestive of multiple sclerosis. Minneboo A, Barkhof F, Polman CH, Uitdehaag BM, Knol DL, Castelijns JA. Arch Neurol; 2004 Feb 26; 61(2):217-21. PubMed ID: 14967769 [Abstract] [Full Text] [Related]
11. Impact of cognitive impairment on coping strategies in multiple sclerosis. Goretti B, Portaccio E, Zipoli V, Hakiki B, Siracusa G, Sorbi S, Amato MP. Clin Neurol Neurosurg; 2010 Feb 26; 112(2):127-30. PubMed ID: 19969413 [Abstract] [Full Text] [Related]
12. Cognitive dysfunction in patients with clinically isolated syndromes or newly diagnosed multiple sclerosis. Glanz BI, Holland CM, Gauthier SA, Amunwa EL, Liptak Z, Houtchens MK, Sperling RA, Khoury SJ, Guttmann CR, Weiner HL. Mult Scler; 2007 Sep 26; 13(8):1004-10. PubMed ID: 17623735 [Abstract] [Full Text] [Related]
13. Accuracy of MRI criteria for dissemination in space for the diagnosis of multiple sclerosis in patients with clinically isolated syndromes. Díaz-Sánchez M, Mayra Gómez-Moreno S, Asunción Morales-Otal M, Ramos-González A, Benito-León J. Mult Scler; 2010 May 26; 16(5):576-80. PubMed ID: 20194582 [Abstract] [Full Text] [Related]
14. Prediction of neuropsychological impairment in multiple sclerosis: comparison of conventional magnetic resonance imaging measures of atrophy and lesion burden. Benedict RH, Weinstock-Guttman B, Fishman I, Sharma J, Tjoa CW, Bakshi R. Arch Neurol; 2004 Feb 26; 61(2):226-30. PubMed ID: 14967771 [Abstract] [Full Text] [Related]
15. A representative cohort of patients with non-progressive multiple sclerosis at the age of normal life expectancy. Skoog B, Runmarker B, Winblad S, Ekholm S, Andersen O. Brain; 2012 Mar 26; 135(Pt 3):900-11. PubMed ID: 22366800 [Abstract] [Full Text] [Related]
16. A single, early magnetic resonance imaging study in the diagnosis of multiple sclerosis. Rovira A, Swanton J, Tintoré M, Huerga E, Barkhof F, Filippi M, Frederiksen JL, Langkilde A, Miszkiel K, Polman C, Rovaris M, Sastre-Garriga J, Miller D, Montalban X. Arch Neurol; 2009 May 26; 66(5):587-92. PubMed ID: 19433658 [Abstract] [Full Text] [Related]
20. Conversion of amnestic Mild Cognitive Impairment to dementia of Alzheimer type is independent to memory deterioration. Rozzini L, Chilovi BV, Conti M, Bertoletti E, Delrio I, Trabucchi M, Padovani A. Int J Geriatr Psychiatry; 2007 Dec 26; 22(12):1217-22. PubMed ID: 17562522 [Abstract] [Full Text] [Related] Page: [Next] [New Search]